Web of Science: 2 citas, Scopus: 3 citas, Google Scholar: citas,
Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice
Latorre,Irene (Institut Germans Trias i Pujol. Servei de Microbiologia)
Mínguez, Sonia (Institut Germans Trias i Pujol. Servei de Reumatologia)
Carrascosa, José-Manuel (Institut Germans Trias i Pujol. Servei de Dermatologia)
Naves, Juan (Institut Germans Trias i Pujol. Servei de Digestiu)
Villar-Hernández, Raquel (Institut Germans Trias i Pujol. Servei de Microbiologia)
Muriel, Beatriz (Institut Germans Trias i Pujol. Servei de Microbiologia)
Prat, Cristina (Institut Germans Trias i Pujol. Servei de Microbiologia)
García-García, Esther (Institut Germans Trias i Pujol. Servei de Microbiologia)
Casas, Irma (Institut Germans Trias i Pujol. Servei de Medicina Preventiva)
Domènech, Eugeni (Institut Germans Trias i Pujol. Servei de Digestiu)
Ferrándiz, Carlos (Institut Germans Trias i Pujol. Servei de Dermatologia)
Mateo, Lourdes (Institut Germans Trias i Pujol. Servei de Reumatologia)
Domínguez, Jose (Institut Germans Trias i Pujol. Servei de Microbiologia)
Universitat Autònoma de Barcelona

Fecha: 2017
Resumen: Background. Clinical accuracy of IGRAs remains unclear on patients with immune-mediated inflammatory diseases (IMIDs). Here, we assess the impact of immunosuppressants and IMIDs on QuantiFERON-TB Gold In-Tube (QFN-G-IT) and T-SPOT. TB accuracy. Methods. Patients with IMIDs who required latent tuberculosis infection (LTBI) screening were enrolled and classified into: (i) 50 patients with inflammatory rheumatic diseases, (ii) 50 patients with psoriasis and (iii) 30 patients with Crohn's disease. A total of 44 healthy individuals without immunosuppression were also included as controls. Tuberculin skin test (TST), T-SPOT. TB and QFN-G-IT assays were performed. IGRAs were performed following manufacturer's instructions. Results. Immunosuppressant's intake was more frequent on patients with Crohn's disease and psoriasis. Positive IGRAs and TST results were reduced in Crohn's disease patients, whereas rate of indeterminate T-SPOT. TB results was increased in this group with respect to the other IMIDs analysed and controls. When IFN-γ response was studied, the levels of this cytokine after mitogen stimulation were significantly lower in Crohn's and inflammatoryrheumatic diseases than in psoriasis. Interestingly, psoriatic patients were the only ones not receiving corticosteroids. Furthermore, a negative correlation was observed between the IFN-γ secreted after mitogen stimulation and corticosteroids dose. Conclusions. IMIDs seem to negatively affect the clinical accuracy of IGRAs, being Crohn's disease patients the most affected individuals due to their concomitant drug-profile and impaired immune response.
Nota: Altres ajuts: Sociedad Española de Neumología y Cirugía Torácica (SEPAR); Societat Catalana de Reumatologia (SCR); CERCA Programme/Generalitat de Catalunya
Nota: Número d'acord de subvenció ISCIII/PI13/01546
Nota: Número d'acord de subvenció ISCIII/PI16/01912
Derechos: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Lengua: Anglès.
Documento: article ; recerca ; publishedVersion
Publicado en: Plos one, Vol. 12 Núm. 12 (december 2017) , p. 1-11

DOI: 10.1371/journal.pone.0189202
PMID: 29216277


11 p, 1.1 MB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Artículos > Artículos de investigación
Artículos > Artículos publicados

 Registro creado el 2018-10-26, última modificación el 2019-07-17



   Favorit i Compartir